BAYERCROP:NSE-Bayer CropScience Limited (INR)

COMMON STOCK | Agricultural Inputs | NSE

Last Closing Price

INR 5,983.30

Change

-151.75 (-2.47)%

Market Cap

INR 268.79B

Volume

0.04M

Average Target Price

INR 6,215.50 (+3.88%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products in India. It also provides pharmaceutical products, such as prescription products primarily for cardiology, oncology, gynecology, hematology, and ophthalmology; and diagnostic imaging equipment and other contrast agents. In addition, the company offers consumer health products that are used as a daily health solutions to treat minor illness; and animal health solutions for the prevention and treatment of diseases in companion and farm animals, as well as sells and distributes hybrid seeds. It also exports its products. The company was incorporated in 1958 and is based in Thane, India. Address: Bayer House, Thane, India, 400 607

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-09-22 )

Largest Industry Peers for Agricultural Inputs

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
UPL:NSE UPL Limited

-3.05 (-0.57%)

INR404.29B 19.04 9.11
PIIND:NSE PI Industries Limited

-47.60 (-2.45%)

INR287.66B 56.02 36.74
COROMANDEL:NSE Coromandel International Limit..

+0.55 (+0.07%)

INR234.55B 19.15 13.05
CHAMBLFERT:NSE Chambal Fertilisers and Chemic..

-4.75 (-3.11%)

INR61.45B 4.71 7.43
RALLIS:NSE Rallis India Limited

-13.60 (-4.60%)

INR54.77B 27.79 16.79
BHARATRAS:NSE Bharat Rasayan Limited

-61.45 (-0.66%)

INR39.38B 90.12 61.48
DHANUKA:NSE Dhanuka Agritech Limited

-8.00 (-1.02%)

INR37.09B 21.90 15.55
FACT:NSE The Fertilisers And Chemicals ..

-1.70 (-3.81%)

INR27.70B 3.49 3.90
RCF:NSE Rashtriya Chemicals and Fertil..

-1.25 (-2.78%)

INR24.08B 23.10 9.67
SHARDACROP:NSE Sharda Cropchem Limited

-10.15 (-3.78%)

INR23.37B 14.62 7.12

ETFs Containing BAYERCROP

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Agricultural Inputs)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 65.37% 93% A 91% A-
Dividend Return 0.94% 55% F 60% D-
Total Return 66.31% 93% A 91% A-
Trailing 12 Months  
Capital Gain 77.77% 88% B+ 92% A-
Dividend Return 1.01% 44% F 62% D-
Total Return 78.78% 88% B+ 92% A-
Trailing 5 Years  
Capital Gain 61.28% 63% D 74% C
Dividend Return 2.80% 28% F 29% F
Total Return 64.09% 63% D 74% C
Average Annual (5 Year Horizon)  
Capital Gain 5.97% N/A N/A N/A N/A
Dividend Return 0.47% N/A N/A N/A N/A
Total Return 6.43% N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 23.89% N/A N/A N/A N/A
Risk Adjusted Return 26.94% N/A N/A N/A N/A
Market Capitalization 268.79B 93% A 94% A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Agricultural Inputs)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 43.10 12% F 20% F
Price/Book Ratio 9.90 12% F 5% F
Price / Cash Flow Ratio 40.37 10% F 9% F
EV/EBITDA 30.27 12% F 15% F
Management Effectiveness  
Return on Equity 19.72% 81% B- 86% B
Return on Invested Capital 18.02% 93% A 90% A-
Return on Assets 11.47% 96% A 94% A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.61 83% B 77% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector